BD Shares 510(k) Review Experience With FDA, Urges Others To Do The Same
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers should inform FDA about industry experiences with premarket reviews to better identify problems with the process, BD exec Patricia Shrader advocated during a MDUFMA stakeholder meeting in Gaithersburg, Md